ENDOCYTE INC·4

Feb 6, 8:02 PM ET

ENDOCYTE INC 4

4 · ENDOCYTE INC · Filed Feb 6, 2015

Insider Transaction Report

Form 4
Period: 2015-02-04
Nguyen Binh
VP of Clinical Affairs
Transactions
  • Award

    Common Stock

    2015-02-04+8,75018,950 total
  • Tax Payment

    Common Stock

    2015-02-06$5.14/sh708$3,63918,242 total
  • Award

    Stock Option (right to buy)

    2015-02-04+52,50052,500 total
    Exercise: $5.10Exp: 2025-02-04Common Stock (52,500 underlying)
Footnotes (3)
  • [F1]Represents restricted stock units that will vest and be paid 1/3 annually over a period of 3 years beginning on February 4, 2016, in the form of one share of common stock for each restricted stock unit.
  • [F2]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 1,875 restricted stock units in the form of Company common stock on a one-for-one basis on February 6, 2015.
  • [F3]Shares subject to the option vest 1/3 annually over a period of 3 years beginning on February 4, 2016.

Documents

1 file
  • 4
    v400765_4.xmlPrimary

    OWNERSHIP DOCUMENT